Enoxaparin versus unfractionated heparin in patients treated with tirofiban, aspirin and an early conservative initial management strategy: results from the A phase of the A-to-Z trial.
de Lemos
James A
JA
Donald W. Reynolds Cardiovascular Clinical Research Center, 5323 Harry Hines Blvd, Rm HA 9.133, UT Southwestern Medical Center, Dallas, TX 75390-9047, USA. james.delemos@utsouthwestern.edu
Blazing
Michael A
MA
Wiviott
Stephen D
SD
Brady
William E
WE
White
Harvey D
HD
Fox
Keith A A
KA
Palmisano
Joanne
J
Ramsey
Karen E
KE
Bilheimer
David W
DW
Lewis
Eldrin F
EF
Pfeffer
M
M
Califf
Robert M
RM
Braunwald
Eugene
E
D001241:Aspirin / Q000627:therapeutic use*; D003327:Coronary Disease / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D017984:Enoxaparin / Q000627:therapeutic use*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006493:Heparin / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D000077466:Tirofiban; D016896:Treatment Outcome; D014443:Tyrosine / Q000031:analogs & derivatives* / Q000627:therapeutic use*
D017984:Enoxaparin; D005343:Fibrinolytic Agents; D014443:Tyrosine; D006493:Heparin; D000077466:Tirofiban; D001241:Aspirin